Testing effectiveness (Phase 2)WithdrawnNCT05365100What this trial is testingBN102 in Patients With Previously Treated CLL/SLL and B-cell NHLWho this might be right forCLL/SLLNHL BioNova Pharmaceuticals (Shanghai) LTD.
Testing effectiveness (Phase 2)Looking for participantsNCT04002947What this trial is testingAcalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaWho this might be right forNon-Hodgkin's LymphomaDiffuse Large B-Cell LymphomaDLBCL+1 more National Cancer Institute (NCI) 132
Large-scale testing (Phase 3)WithdrawnNCT00551239What this trial is testingFludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWho this might be right forLeukemiaLymphoma CTI BioPharma
Very early researchUnknownNCT04639739What this trial is testingAnti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma.Who this might be right forNHL Xinqiao Hospital of Chongqing 9
Testing effectiveness (Phase 2)Looking for participantsNCT05554939What this trial is testingAllogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHLWho this might be right forNon Hodgkin's Lymphoma Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT02727803What this trial is testingPersonalized NK Cell Therapy in CBTWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia+23 more M.D. Anderson Cancer Center 100
Early research (Phase 1)UnknownNCT04296461What this trial is testingStudy of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Non-Hodgkin Lymphoma UWELL Biopharma 20
Testing effectiveness (Phase 2)Looking for participantsNCT06550141What this trial is testingEmapalumab Prevention of CAR-T Cell Associated ToxicitiesWho this might be right forLarge B-cell LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+4 more Marcela V. Maus, M.D.,Ph.D. 28
Testing effectiveness (Phase 2)Study completedNCT00003572What this trial is testingTotal-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00285428What this trial is testingStudy of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Gilead Sciences 82
Early research (Phase 1)Active Not RecruitingNCT05737628What this trial is testingFirst-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228Who this might be right forLymphoma Byondis B.V. 17
Testing effectiveness (Phase 2)Study completedNCT04359784What this trial is testingAnakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell TherapyWho this might be right forB-Cell Non-Hodgkin Lymphoma Fred Hutchinson Cancer Center 27
Very early researchEnded earlyNCT03272633What this trial is testingIrradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more Rutgers, The State University of New Jersey 2
Testing effectiveness (Phase 2)Study completedNCT00005811What this trial is testingTopotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentWho this might be right forAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+17 more National Cancer Institute (NCI) 77
Large-scale testing (Phase 3)Looking for participantsNCT07582432What this trial is testingA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaWho this might be right forChronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma Grifols Biologicals, LLC 49
Early research (Phase 1)Looking for participantsNCT06191887What this trial is testingB-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic MalignanciesWho this might be right forB-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+12 more Mayo Clinic 27
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748364What this trial is testingGlofitamab in B-NHL Using Mid-Therapy Intratumoral TranscriptomicsWho this might be right forRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Mantle Cell Lymphoma Joshua Brody 16
Large-scale testing (Phase 3)Study completedNCT00003938What this trial is testingLiposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer PatientsWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 115